Ticker: FATE

Company: FATE THERAPEUTICS INC

Person: Bahram Valamehr, director, officer

Transaction date: Jan. 9, 2026

Reporting date: Jan. 12, 2026

Average share price: 1.0708

Sold 5190.0 shares for 5557.45